Compare IRMD & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRMD | ASTH |
|---|---|---|
| Founded | 1992 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2014 | 2015 |
| Metric | IRMD | ASTH |
|---|---|---|
| Price | $96.20 | $25.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 60.3K | ★ 350.5K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 1.75 | 0.46 |
| Revenue | $83,814,000.00 | ★ $519,907,752.00 |
| Revenue This Year | $11.99 | $27.32 |
| Revenue Next Year | $9.91 | $10.84 |
| P/E Ratio | $55.08 | ★ $53.33 |
| Revenue Growth | 14.43 | ★ 45.90 |
| 52 Week Low | $47.48 | $18.08 |
| 52 Week High | $107.90 | $34.80 |
| Indicator | IRMD | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 58.51 |
| Support Level | $92.51 | $20.62 |
| Resistance Level | $98.44 | $25.41 |
| Average True Range (ATR) | 2.89 | 1.03 |
| MACD | -0.53 | -0.01 |
| Stochastic Oscillator | 25.83 | 81.70 |
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.